Jump to top menu Jump to main menu Jump to content
Research project

The Rotterdam Asthma Trial

Status: Ongoing (September 2017-2022)

Protocolled practice nurse-led care for children 6-12 years with asthma in primary care. Primary objective of the study is to determine the effect of protocolled practice nurse-led asthma care for children aged 6 to 12 years old in primary care on asthma control (compared to usual care).

What we do

Background
In children with asthma, daily symptoms and exacerbations have a significant impact on the quality of life of both children and parents. Trials in adults suggest that asthma control is better when patients receive a regular medical review. This study aims to determine whether protocolled practice nurse-led asthma care for children in primary care provides more effective asthma control than usual care.

Hypothesis
We hypothesize that protocolled nurse-led care by the practice nurse will improve asthma control and quality of life.

Methods
A total of 180 children aged 6 to 12 years with asthma will be included. Patients will randomly be allocated per cluster to either protocolled nurse-led care by the practice nurse or usual care by their general practitioner. The effect of treatment will be evaluated by questionnaires, spirometry and follow-up data during the consultations with the practice nurse. Statistical analysis will be based on both the intention-to-treat and the per-protocol principle.

Primary outcome
The primary outcome is asthma control measured by the Childhood Asthma Control Test (C-ACT)

Secondary outcomes
Secondary outcomes are frequency and severity of exacerbations, healthcare costs, (disease specific) quality of life, results of spirometry and patient/nurse/GP satisfaction with delivered care. Outcomes are measured 3, 6, 12 and 18 months after baseline.
ZonMw HGOG (grant number 839110021).
Bousema S, Verwoerd AJ, Goossens LM, Bohnen AM, Bindels PJE, Elshout G. Protocolled practice nurse-led care for children with asthma in primary care: protocol for a cluster randomised trial. BMJ Open. 2019 Sep 27;9(9):e022922. doi: 10.1136/bmjopen-2018-022922.

Dr. G. Elshout (co-promotor), g.elshout@erasmusmc.nl
Dr. A.M. Bohnen a.bohnen@erasmusmc.nl
Prof. Dr. P.J.E. Bindels, p.bindels@erasmusmc.nl (promotor)

Contact address for the project: astma@erasmusmc.nl.